Company / Income Tax per Share
Spyre Therapeutics, Inc. Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
-$0.00
FY2025
5-year range
-$0.01 / $0.00
FY2021-FY2025
Trend
-117.6%
vs FY2024
Sector context
#167 of 201
Health Care
What the data says
Spyre Therapeutics, Inc.'s income tax per share of $-0.00 is lower than 83% of companies in the Health Care sector (FY2025). Income Tax per Share has fluctuated over the past 10 years, ranging from $-0.01 in FY2023 to $0.00 in FY2021.
Based on SEC 10-K filings.
-0.00 in FY2025.
Increased from $-0.01 to $-0.00 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 201This company -$0.00 Sector average $1.35
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, income tax per share decreased 117.6% year-over-year.
- Ranks #167 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2021.
- Lowest income tax per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.00 | -117.6% |
| FY2024 | $0.00 | +114.2% |
| FY2023 | -$0.01 | - |
| FY2022 | $0.00 | -100.0% |
| FY2021 | $0.00 | - |
| FY2020 | $0.00 | - |
| FY2019 | $0.00 | - |
| FY2018 | $0.00 | - |
| FY2017 | $0.00 | - |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026